Italian Study Group on Complicated Diverticulosis
Nyckelord
Abstrakt
Datum
Senast verifierad: | 11/30/2010 |
Först skickat: | 01/11/2011 |
Beräknad anmälan inlämnad: | 01/11/2011 |
Först publicerad: | 01/12/2011 |
Senaste uppdatering skickad: | 01/20/2011 |
Senaste uppdatering publicerad: | 01/23/2011 |
Faktiskt startdatum för studien: | 12/31/1995 |
Uppskattat primärt slutdatum: | 11/30/1999 |
Beräknat slutfört datum: | 11/30/1999 |
Tillstånd eller sjukdom
Intervention / behandling
Drug: Acute Diverticulitis
Procedure: Acute Diverticulitis
Fas
Armgrupper
Ärm | Intervention / behandling |
---|---|
Acute Diverticulitis | Drug: Acute Diverticulitis |
Urvalskriterier
Kön som är berättigade till studier | All |
Testmetod | Non-Probability Sample |
Accepterar friska volontärer | Ja |
Kriterier | Inclusion Criteria: All consecutive patients with left sided acute diverticulitis diagnosed clinically by the presence of: - abdominal pain, - leukocytosis (>11x109) - fever >38°C and confirmed by imaging (CT scan, ultrasonography, water soluble contrast enema) The CT criteria for the diagnosis included at least one of: - a localized thickening (≥4 mm) of the colonic wall - signs of inflammation of the pericolic fat - abscess - extraluminal air - extraluminal contrast The ultrasound criteria included at least two of: - bowel wall thickening (>4 mm) - diverticular inflammation - pericolic fat edema - intramural or pericolic inflammatory mass - intramural fistula Water soluble contrast enema criteria included at least two of: - segmental luminal narrowing - a tethered mucosa - a mass effect - extravasation of contrast - the presence of extraluminal air Exclusion Criteria: - inflammatory bowel disease - irritable bowel syndrome - colorectal cancer - diseases precluding adequate follow up |
Resultat
Primära resultatåtgärder
1. to assess the rate of recurrence of acute diverticulitis requiring hospitalization during the follow-up period [10 years]
Sekundära resultatåtgärder
1. to assess the risks of emergency surgery, stoma and disease-related mortality during the follow up [10 years]